0

Purchase Short-Term Access

Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable
Stuart J. Connolly, MD; John W. Eikelboom, MBBS; Jennifer Ng, MSc; Jack Hirsh, MD; Salim Yusuf, MD; Janice Pogue, MSc, MA; Raffaele de Caterina, MD, PhD; Stefan Hohnloser, MD; Robert G. Hart, MD; on behalf of the ACTIVE (Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events) Steering Committee and Investigators
Annals of Internal Medicine 2011;155:579-586. doi:10.7326/0003-4819-155-9-201111010-00004

Purchase Online access to this article for 24 hours
Buy Now
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)